VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $328,000 | -50.6% | 20,000 | -60.0% | 0.01% | -61.5% |
| Q3 2019 | $664,000 | -41.1% | 50,000 | -37.5% | 0.01% | -56.7% |
| Q2 2019 | $1,127,000 | -27.9% | 80,000 | -5.9% | 0.03% | -23.1% |
| Q1 2019 | $1,564,000 | -32.0% | 85,000 | -3.4% | 0.04% | -59.4% |
| Q4 2018 | $2,300,000 | +150.5% | 88,000 | +120.0% | 0.10% | +300.0% |
| Q3 2018 | $918,000 | +22.4% | 40,000 | +1.6% | 0.02% | +33.3% |
| Q2 2018 | $750,000 | +11.3% | 39,358 | -1.6% | 0.02% | -14.3% |
| Q1 2018 | $674,000 | -11.3% | 40,000 | -20.0% | 0.02% | +5.0% |
| Q4 2017 | $760,000 | -22.8% | 50,000 | -9.1% | 0.02% | -45.9% |
| Q3 2017 | $985,000 | +4.2% | 55,000 | -5.2% | 0.04% | -7.5% |
| Q2 2017 | $945,000 | +12.5% | 58,000 | -3.3% | 0.04% | +21.2% |
| Q1 2017 | $840,000 | +5.3% | 60,000 | +20.0% | 0.03% | -15.4% |
| Q4 2016 | $798,000 | +299.0% | 50,000 | +316.7% | 0.04% | +225.0% |
| Q3 2016 | $200,000 | +138.1% | 12,000 | +20.0% | 0.01% | +200.0% |
| Q1 2016 | $84,000 | -27.6% | 10,000 | -20.0% | 0.00% | -50.0% |
| Q4 2015 | $116,000 | -17.7% | 12,500 | 0.0% | 0.01% | +33.3% |
| Q3 2015 | $141,000 | -68.2% | 12,500 | -64.3% | 0.01% | -66.7% |
| Q2 2015 | $444,000 | +2.8% | 35,000 | -24.6% | 0.02% | -5.3% |
| Q1 2015 | $432,000 | -39.7% | 46,400 | -7.2% | 0.02% | -24.0% |
| Q4 2014 | $716,000 | +6.1% | 50,000 | -23.1% | 0.02% | +56.2% |
| Q3 2014 | $675,000 | -44.4% | 65,000 | -13.3% | 0.02% | -38.5% |
| Q2 2014 | $1,214,000 | +54.5% | 75,000 | +55.1% | 0.03% | +62.5% |
| Q1 2014 | $786,000 | +5.5% | 48,360 | -19.4% | 0.02% | 0.0% |
| Q4 2013 | $745,000 | -15.0% | 60,000 | -25.0% | 0.02% | +77.8% |
| Q3 2013 | $876,000 | +8.4% | 80,000 | -20.0% | 0.01% | -62.5% |
| Q2 2013 | $808,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |